Speech-Language Pathologists in Traverse City, MI Accepting Medicare

47 Speech-Language Pathologists found. Showing 41 - 47

Susan Carol Spencer, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-9167    Fax: 231-935-8609

Sara Pryde Tucker, MA-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-735-3460

Rebecca Weissmann, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1810 Chartwell Dr, Traverse City, MI 49696 Phone: 231-929-2354

April Bluck Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 415 Munson Ave, Ste 103, Traverse City, MI 49686 Phone: 800-968-6866

Rena Spencer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5208 Liberty Dr, Traverse City, MI 49685 Phone: 231-357-4515

Jessica Nicole Newberry, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5123 N Royal Dr, Traverse City, MI 49684 Phone: 319-298-3832

Kristen Thomas, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1810 Chartwell Dr, Traverse City, MI 49696 Phone: 231-929-2354    Fax: 231-929-2853

News Archive

How lifesaving organs for transplant go missing in transit

When a human heart was left behind by mistake on a Southwest Airlines plane in 2018, transplant officials downplayed the incident. They emphasized that the organ was used for valves and tissues, not to save the life of a waiting patient, so the delay was inconsequential.

Measure of ED threat perceptions could help identify patients at risk for cardiac-induced PTSD

A brief tool assessing emergency department threat perceptions has clinical utility for providers to identify patients at risk for developing cardiac-induced PTSD and is critical to inform research on whether threat may be modified in-ED to reduce post-traumatic stress disorder (PTSD) incidence.

Cadence confirms FDA dosing recommendations for OFIRMEV

Cadence Pharmaceuticals, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg.

Deep sleep maintains normal glucose control

Suppression of slow-wave sleep in healthy young adults significantly decreases their ability to regulate blood-sugar levels and increases the risk of type 2 diabetes, report researchers at the University of Chicago Medical Center in the "Early Edition" of the Proceedings of the National Academy of Science, available online as soon as Dec. 31, 2007.

Mason researchers join NIH grant to investigate early life environmental exposures

Rosemary Higgins, Associate Dean for Research, College of Health and Human Services, and Germaine Buck Louis, Dean, CHHS, received $1,457,607 from the National Institutes of Health for: "ECHO Consortium on Perinatal Programming of Neurodevelopment."

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3(current)